SOL Global pays €1.8m for 25% stake in medical cannabis firm GreenLight

The US-focused company has an option to increase its share to 51% in the Irish firm as it positions itself for growth in European markets.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this